A major focus of our work is to identify transcriptional and epigenetic regulatory controls underlying the development of human cortical interneurons and to understand how their dysregulation contributes to neurodevelopmental disorders. The mammalian cerebral cortex consists of two major types of neurons, excitatory glutamatergic projection neurons that convey information to different regions of the brain and GABAergic interneurons that provide local inhibitory inputs to modulate responses of projection neurons and prevent over-excitation. Imbalances between excitatory and inhibitory neuronal activities can emerge during cortical development. These imbalances often reduce inhibitory signaling through dysfunctional specification, migration, differentiation, or survival of interneurons. Interneuron hypoplasia or dysfunction contributes to many neurological disorders, including epilepsy, schizophrenia, autism spectrum disorder, and intellectual disability syndromes.
We are modeling gene regulatory networks that control human cortical interneuron specification and differentiation at a genome-wide level by generating mature interneurons from human pluripotent stem cells (embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs)).
Human pluripotent stem cell-derived cortical interneurons (hcINs): electrophysiology and engraftment into the murine adult and neonatal brain. (A) Scheme: Synapsin (SYN)-GFP expressing hcINs (after PSA-NCAM selection; scale bars=100µM) were transplanted into the (B) hippocampus (CA3) of adult mice (B’=boxed region in B; scale bar=50µM) or (C) cortex of post-natal 2 NOD/SCID mice (C’=boxed region in C, scale bar=100µM). B-C: 30 days post-transplantation shown. The ‘scan slide’ mode in the Nikon confocal software was used to assemble a composite view of the whole brain slice from several individual images. (D) Scheme: SYN-GFP expressing hcINs (after PSA-NCAM selection; scale bar=100µM) were co-cultured on rat cortical astrocyte feeders for 3 wks. prior to electrophysiology. (E) Sub- and supra-threshold stimulation by injection of depolarizing current (52 and 56 pA for 40 msec). (F) Multiple action potentials during injection of depolarizing current (56 pA for 800 msec). (G) Spontaneous inhibitory postsynaptic currents (sIPSCS) recorded at -80 and -20 mV are inhibited by exposure to 100 µM bicuculline methiodide (black bars). (H) Whole-cell currents recorded during a voltage step from -80 to +50 mV in control (black trace) and 0.5 µM tetrodotoxin (TTX, red trace). (I) Currents evoked by exposure to 100 µM kainate (K), NMDA, GABA, and glycine (gly). (J) Evoked IPSC elicited by a presynaptic voltage step. (K) Electrophysiological properties of hESC-derived hcINs (mean +/- SEM).
We are integrating genome-wide binding profiles of key transcription factors and chromatin regulators, developmental transcriptome and epigenome changes, and effects of manipulating these activities. This work has revealed new regulators of interneuron development, including transcriptional and chromatin modifying activities and non-coding RNAs, enriched in and/or involved in interneuron specification and differentiation.
Integrating genome-wide binding profile of the transcription factor NKX2-1 and enriched gene expression in hPSC-derived interneuron progenitors (hMGEs) and neurons (hcINs). (A) RNA-seq data for cortical interneurons. k-means clustered data, based upon expression z-scores. (B-C) NKX2-1-associated genes with enriched expression at d15 (B) or d35 (C)
We have also defined genes with interneuron-enriched expression whose mutation contributes to human neurodevelopmental disorders, including inherited epilepsies and autism spectrum disorder. In collaboration with the WU Intellectual and Developmental Disability Research Center (IDDRC), we are deriving iPSCs from epilepsy and autism patients with mutations in some of these genes and are performing directed differentiation into cortical excitatory and inhibitory neurons and cerebral organoids. These are subjected to a battery of assays to define developmental, cellular, molecular, and functional abnormalities that contribute to the disorder. We can use these models to assess the relative contributions of genetic background versus pathogenic mutations, by comparisons of isogenic neurons with versus without engineered correction of mutations. We are also using these models to assess how differential expressivity of a disorder among family members carrying a known pathogenic mutation manifests in cellular, molecular, and functional differences between neurons from these family members.
Requirements for the epilepsy and IDD gene, CHD2, in cortical interneuron development. (A) Differentially regulated genes upon CHD2 knockdown (KD), with some highlighted. (B) Genes with reduced expression in the CHD2 KD RNA-seq were also diminished in hMGEs with biallelic CHD2 KO vs wild-type hMGEs. (H-I) CHD2 KO reduced TUBB3 and HCN4 immunopositive cells and (J) neurite length. (K) Currents mediated by TTX-sensitive sodium channels during steps from a holding potential of -80 mV to test potentials ranging from -60 to +35 mV. Traces were obtained by subtracting currents recorded during exposure to TTX from currents recorded in control external solution without TTX. Peak inward current is plotted as a function of test potential for wild type (black) and knock out (red) cells. (L) Phase plots of action potentials from 13 wild type (grey) and 9 knock out (red) neurons. The initial increase in dV/dt occurs at more negative membrane potentials in knock out cells, indicating a difference in action potential threshold. Inset at top right plotted on expanded scales, lower right the action potentials are aligned at the point of maximal upslope. For B, I-J, p-values defined by unpaired student’s t-test, *<0.05, **<0.01, ***<0.001. In D, H, scale bar=50µM.